These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 56044)
1. Blood transfusion practice: facts and fallacies. Shapiro M S Afr Med J; 1976 Jan; 50(4):105-9. PubMed ID: 56044 [TBL] [Abstract][Full Text] [Related]
2. [Hepatitis-associated antigen and antibodies after multiple transfusions in children and juveniles with severe and moderately severe haemophilia (author's transl)]. Schwartz B; Landbeck G Dtsch Med Wochenschr; 1973 Oct; 98(43):2016-9. PubMed ID: 4744372 [No Abstract] [Full Text] [Related]
3. Cryoprecipitate. Armstrong D S Afr Med J; 1975 Jul; 49(31):1245-7. PubMed ID: 1154189 [No Abstract] [Full Text] [Related]
4. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions. Schimpf K; Mannucci PM; Kreutz W; Brackmann HH; Auerswald G; Ciavarella N; Mösseler J; DeRosa V; Kraus B; Brueckmann C N Engl J Med; 1987 Apr; 316(15):918-22. PubMed ID: 3102963 [TBL] [Abstract][Full Text] [Related]
5. Hemophilia, hepatitis and HAA. Lewis JH Vox Sang; 1970; 19(3):406-9. PubMed ID: 5502767 [No Abstract] [Full Text] [Related]
6. The clinical use of plasma fractions. Hässig A Haematologia (Budap); 1974; 8(1-4):393-400. PubMed ID: 4142622 [No Abstract] [Full Text] [Related]
7. Jaundice and hepatitis B antigen-antibody in hemophilia. Lewis JH; Maxwell NG; Brandon JM Transfusion; 1974; 14(3):203-11. PubMed ID: 4835949 [No Abstract] [Full Text] [Related]
8. Prevalence of delta hepatitis virus in South Africa. Dusheiko GM; Song E; Botha JF; Conradie J S Afr Med J; 1985 Mar; 67(11):398. PubMed ID: 3983715 [No Abstract] [Full Text] [Related]
9. [Hepatitis in hemophilia]. Eggeling B; Sennekamp J; Brackmann HH; Werner I Schweiz Med Wochenschr; 1974 Sep; 104(36):1250-5. PubMed ID: 4445853 [No Abstract] [Full Text] [Related]
11. Estimation of the probability of post transfusion hepatitis in hemophilia treatment. Davis CE; Grizzle JE; Bryan JA Biometrics; 1973 Jun; 29(2):386-92. PubMed ID: 4709517 [No Abstract] [Full Text] [Related]
12. [Emergency therapy and ambulatory care in hemophilia]. Remde W Z Gesamte Inn Med; 1979 Jun; 34(12):154-6. PubMed ID: 315673 [No Abstract] [Full Text] [Related]
13. Plasmapheresis in hemophilia utilizing angle head centrifugation, a new parameter in blood component therapy. Borucki DT; Peterson CA Bibl Haematol; 1965; 23():1210-3. PubMed ID: 5885206 [No Abstract] [Full Text] [Related]
14. Addition of hepatitis-B immunoglobulin to clotting factors. Smit Sibinga CT; Das PC; Nieweg HO Lancet; 1980 Sep; 2(8193):537. PubMed ID: 6105586 [No Abstract] [Full Text] [Related]
15. Progress and problems in hemophilia and von Willebrand's disease. Abildgaard CF Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429 [No Abstract] [Full Text] [Related]
17. [Hemolysins and isoagglutinins in substitute preparations containing factor VIII]. Göbel U; Ranke M Blut; 1972 Jun; 24(6):365-71. PubMed ID: 5057724 [No Abstract] [Full Text] [Related]
18. Studies on the Australia-SH antigen in Norway. Berg K Vox Sang; 1970; 19(3):384-90. PubMed ID: 4100648 [No Abstract] [Full Text] [Related]
19. The prevalence of hepatitis B (Australia) antigen in Southern Africa. Bersohn I; MacNab GM; Pyzikowska J; Kew MC S Afr Med J; 1974 May; 48(22):941-4. PubMed ID: 4834625 [No Abstract] [Full Text] [Related]